Principal Consultant Jason Bogroff asks us to think about data use differently; not as discrete reports, but instead as an ongoing process of drill-down, questioning and analysis to reveal untapped value from our data assets.
With a sharp focus on the pharmaceutical, biotechnology and healthcare industries, we are devoted to creating and delivering transformational solutions to our clients to benefit patients around the world.
PRx is huge. Most of the money is coming from drugs. Everyone is talking about the science and the challenges with getting PRx to work in hospitals. Yet no one is talking about commercial strategies, and it's time to do so now.